| [1] |
Gyomber D, Lawrentschuk N, Ranson DL, et al. An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy[J]. BJU Int, 2006, 97(4):758-761.
|
| [2] |
Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation[J]. J Am Coll Cardiol, 2005, 45(6):947-953.
|
| [3] |
de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)[J]. J Am Coll Cardiol, 2008, 51(10):986-990.
|
| [4] |
Murray J, Saxena S, Millett C, et al. Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007)[J]. Fam Pract, 2010, 27(4):430-438.
|
| [5] |
Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis[J]. J Intern Med, 2005, 257(5):399-414.
|
| [6] |
Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease[J]. Eur Heart J, 2006, 27(22):2667-2674.
|
| [7] |
Donat R, Wilson I, Raza A, et al. A multicentre prospective, randomised, doubleblind placebo-controlled trial of aspirin during transurethral resection of the prostate (TURP)[J]. J Urol, 2003, 169(2):466-467.
|
| [8] |
Taylor K, Filgate R, Guo DY, et al. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs[J]. BJU Int, 2011, 108(2):45-50.
|
| [9] |
Wenders M, Wenzel O, Nitzke T, et al. Perioperative platelet inhibition in transurethral interventions: TURP/TURB[J]. Int Braz J Urol, 2012, 38(5):606-610.
|
| [10] |
Nielsen JD, Holm-Nielsen A, Jespersen J, et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study[J]. Scand J Urol Nephrol, 2000, 34(3):194-198.
|
| [11] |
Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK[J]. Ann R Coll Surg Engl, 2006, 88(3):280-283.
|
| [12] |
杨毅，陈荣，吴德锋,等.经尿道前列腺电切术术前停服阿司匹林的时机选择[J].浙江实用医学, 2015, 20(3):201-203.
|
| [13] |
袁渊，姚启盛，王晓康,等.高龄前列腺增生患者合并心血管疾病的围手术期处理[J].中华腔镜泌尿外科杂志:电子版, 2013, 7(1):25-28.
|
| [14] |
Rubino AS, Della Corte A, Giordano R, et al. Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting[J]. Eur J Cardiothorac Surg, 2014, 46(2):335.
|
| [15] |
Ong WL, Koh TL, Fletcher J, et al. Perioperative management of antiplatelets and anticoagulants among patients undergoing elective transurethral resection of the Prostate--A single institution experience[J]. J Endourol, 2015, 29(11):1321-1327.
|